Ontogeny of dexamethasone binding and sodium potassium ATPase activity in experimental murine polycystic kidney disease.
The induction of polycystic kidney disease (PKD) by glucocorticoids in newborn mice behaves as a "threshold" trait, with prevalence of PKD varying in different inbred strains after exposure to an inducing steroid. C3H mice (low threshold for PKD) demonstrated greater specific dexamethasone binding than DBA mice (high threshold) on the second day of life. Treatment with methylprednisolone acetate (MPA), a cyst-inducing steroid, down regulated dexamethasone binding earlier than in DBA mice. C3H mice demonstrated greater whole kidney homogenate Na-K ATPase activity than DBA mice within 24h of MPA injection. Specific renal glucocorticoid binding may be a regulator of threshold for murine glucocorticoid induced PKD. Our findings support in vitro evidence that glucocorticoid induced Na-K ATPase activity during critical periods of nephron development is an important regulatory point of this model.
Ogborn
M R
MR
Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Crocker
J F
JF
D000818:Animals; D003907:Dexamethasone / Q000378:metabolism*; D008775:Methylprednisolone; D051379:Mice; D008809:Mice, Inbred C3H; D008811:Mice, Inbred DBA; D007690:Polycystic Kidney Diseases / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*
D003907:Dexamethasone; D000254:Sodium-Potassium-Exchanging ATPase; D008775:Methylprednisolone